Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

Part of paid clinical trials in Chula Vista, California.

Sponsor
Medtronic MiniMed, Inc.
Study ID
NCT07864168
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
2 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Next Generation Extended Wear Sensors — DEVICE
    Disposable Sensor (MMT-5600XNG and MMT-5600X) - labeled as DS5K and referred to as Unity

Study Details

This study will collect sensor data in subjects with T1D or T2D, 2-80 years of age.

Key Dates

First listed
Oct 7, 2026
Start date
Oct 31, 2026
Status verified
Oct 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
1,500 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Next Generation Extended Wear Sensors
    All subjects will wear the sensor. Each subject and subject's parent/guardian/caregiver (if applicable) may insert and tape (if applicable) the study glucose sensors once trained or have them inserted and taped (if applicable) by the trained investigational center staff.

Primary Outcome Measure

Primary Safety Endpoints [ Time Frame: Approximately up to 46 days ]

Central Contacts

Locations (18)

FacilityCityStateZIPSite coordinators
ProScientoChula VistaCalifornia91911
Gloria Keopuhiwa
Elaine Watkins (PRINCIPAL_INVESTIGATOR)
Stanford UniversityPalo AltoCalifornia94304
Bailey Suh
925-389-8516
Rayhan Lal (PRINCIPAL_INVESTIGATOR)
Rady Children's Hospital - San DiegoSan DiegoCalifornia92123
Carla Logan
858-966-8400
Anna Cymbaluk (PRINCIPAL_INVESTIGATOR)
University of California San Francisco UCSF The Madison Clinic for Pediatric DiabetesSan FranciscoCalifornia94158
Avani Narayan
415-514-6234
Laya Ekhlaspour (PRINCIPAL_INVESTIGATOR)
Sansum Diabetes Research InstituteSanta BarbaraCalifornia93105
Alexis Marquardt
Andrew Rhinehart (PRINCIPAL_INVESTIGATOR)
Diablo Clinical Research, Inc.Walnut CreekCalifornia94598
Sonal Sharma
925-930-7267
Mark Christiansen (PRINCIPAL_INVESTIGATOR)
Barbara Davis Center for DiabetesAuroraColorado80045
Christie Beatson
303-724-6761
Satish Garg (PRINCIPAL_INVESTIGATOR)
Barbara Davis Center for DiabetesAuroraColorado80045
Lindsey Towers
Gregory Forlenza (PRINCIPAL_INVESTIGATOR)
Yale University School of MedicineNew HavenConnecticut06511
Marcia DeSousa
Laura Nally (PRINCIPAL_INVESTIGATOR)
University of FloridaGainesvilleFlorida32610
Jennifer Hosford
352-294-5759
Michael Haller (PRINCIPAL_INVESTIGATOR)
University of South Florida (USF) Diabetes and Endocrinology CenterTampaFlorida33612
Elizabeth Doble
813-974-5529
Dorothy Shulman (PRINCIPAL_INVESTIGATOR)
Atlanta Diabetes AssociatesAtlantaGeorgia30318
Research Admin
Bruce Bode (PRINCIPAL_INVESTIGATOR)
Rocky Mountain Clinical ResearchIdaho FallsIdaho83404
Isabella Wenstrom
David Liljenquist (PRINCIPAL_INVESTIGATOR)
Texas Diabetes and EndocrinologyAustinTexas78749
Emmanuel Lopez
512-334-3505
Lindsay Harrison (PRINCIPAL_INVESTIGATOR)
Diabetes and Glandular Disease ClinicSan AntonioTexas78229
JoAnn Hernandez
210-614-8612
Mark Kipnes (PRINCIPAL_INVESTIGATOR)
University of Virginia Health SystemCharlottesvilleVirginia22903
Mark DeBoer (PRINCIPAL_INVESTIGATOR)
Rainier Clinical Research CenterRentonWashington98057
Taylor Smith
425-271-1720
Sheryl Marks (PRINCIPAL_INVESTIGATOR)
Seattle Children'sSeattleWashington98105
Barbara Maslaney
206-884-8540
Catherine Pihoker (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chula Vista, CA

Related Studies